2012•Practical Journal of Cardiac Cerebral Pneumal and Vascular DiseaseRequires access
The Efficacy and Safety of Domestic-Made Rosuvastatin in Low body Weight Female Patients with Dyslipidemia
Wang Hon
Open publisher page 0 citations
Abstract
Objective To evaluate the efficacy and safety of domestic-made rosuvastatin in low body weight female patients with dyslipidemia.Methods 40 low body weight female patients with dyslipidemia toke rosuvastatin 5mg orally once daily for 3 months.The efficacy and safety of this treatment were evaluated after 3 months of treatment by evaluating the changes and compliance rate of TC,LDL-C.Results Comparing with the baseline,the TC and LDL-C decreased after 3 months treatment,which received a significant difference.The compliance rate of TC,LDL-C were 44.6 % and 56.3 % respectively.There were no significant differences when comparing the concentration of TG and HDL-C before and after rosuvastatin treatment.No serious adverse events related to the medication were observed.Conclusion Rosuvastatin may improve the lipid profile of dyslipidemia female patients with low body.